Virtu Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-20,899
Closed -$149K – 2011
2024
Q2
$149K Buy
+20,899
New +$160K 0.01% 774
2020
Q3
– Sell
-10,055
Closed -$66K – 1618
2020
Q2
$66K Buy
+10,055
New +$56.1K 0.01% 964
2019
Q4
$128K Sell
16,685
-4,683
-22% -$27.3K 0.01% 1035
2019
Q3
$113K Sell
21,368
-25,938
-55% -$161K 0.01% 1067
2019
Q2
$264K Buy
+47,306
New +$195K 0.02% 860
2019
Q1
– Sell
-17,402
Closed -$71K – 1944
2018
Q4
$71K Buy
+17,402
New +$90.8K ﹤0.01% 1216
2018
Q2
– Sell
-49,392
Closed -$144K – 2594
2018
Q1
$144K Buy
49,392
+29,759
+152% +$91.9K 0.01% 1479
2017
Q4
$76K Buy
+19,633
New +$84.1K ﹤0.01% 1988

Other funds holding CDMO

Virtu Financial's CDMO Position: Q3 2024 in Review

Virtu Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 20,899 shares — an estimated $149K sold.

Virtu Financial first reported a position in CDMO in Q4 2017 and held it in 8 quarters. The position peaked at $264K in Q2 2019. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Virtu Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 20,899 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $149K.
  • Virtu Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Virtu Financial's Avid Bioservices, Inc. Common Stock position peaked at $264K in Q2 2019.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.